Received: 13 February 2022
Accepted: 22 June 2022
First Online: 31 August 2022
: The analysis of the ECP cohort used data from clinical trial (ClinicalTrials.gov registry number NCT03326895). Each of the 12 site/investigator’s Institutional Review Board (IRB) or Independent Ethics Committee (IEC) approved the protocol and consent form. Informed consent was obtained for all patients. The study was conducted in accordance with Good Clinical Practice (GCP) and the Declaration of Helsinki, as well as any other applicable local state and federal requirements. This analysis of the MCS cohort was conducted based on de-identified data, which do not contain personal identifier information, and thus waived for ethics approval requirements.
: Not applicable.
: The authors declare that they have no competing interests.